Morning Briefing
Summaries of health policy coverage from major news organizations
Wall Street Journal Examines GSK's Open-Source Development For Drug Discovery Plan
The Wall Street Journal examines GlaxoSmithKline's (GSK) plan to share its database of compounds that could treat tropical diseases. The initiative will test how well "open-source principles work for developing new drugs," the newspaper reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
